1. Biondi A, Yokota T, Hansen-Hagge T, Rosii V, Giudici G, Maglia O, BasooG, Tell C, Masera G, Bartram CR (1992) Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia 6: 282–288
2. Bradstock KF, Gottlieb DJ (1995) Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk Lymphoma 18: 1–16.
3. Brisco M, Condon J, Sykes P, Neoh SH, Morley AA (1991) Detection and quantification of neoplastic cells in acute lymphoblastic leukemia by use of polymerase chain reaction. Br J Haematol 79: 21–217
4. Brisco MJ, CondonJ, Hughes E, Neoh SH, Nicholson I, Sykes P, Yauro J, Ekhert H, Waters K, Toogood I, Sehardi R, Morley A (1993) Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Leukemia 7: 1514–1520.
5. Brisco M, Condon J, Highes E, Neoh S, Sykes P, Seshardi R, Toogood I, Waters K, Tauro G, Ekert H, & Morley A (1994) Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet 343: 196–200